Dr. Frank S.f. Hsu, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 21297 Foothill Blvd Ste 102, Hayward, CA 94541 Phone: 510-538-4870 Fax: 510-538-6475 |
News Archive
Theraclone Sciences, Inc., a Seattle-based biotechnology company, and Zenyaku Kogyo Co., Ltd., a pharmaceutical company based in Tokyo, today announced that they have entered into a multi-year research and development agreement.
The European College of Neuropsychopharmacology expresses its deep concern at the recently announced withdrawal by AstraZeneca from neuroscience drug research. AstraZeneca's pull-out is especially disturbing given that it follows a series of similar withdrawals in the last two years by major pharmaceutical companies. There is a growing sense that neuroscience in Europe is now facing a severe crisis.
Four new genes have been added to the growing list of those known to cause increased breast cancer risk when mutated through the efforts of researchers at Huntsman Cancer Institute (HCI) at the University of Utah, who lead an international consortium working to find more gene mutations that cause inherited breast cancer susceptibilities.
The health care debate has Democrats on Capitol Hill and the presidential campaign trail facing renewed pressure to make clear where they stand: Are they for "Medicare for All"? Or will they take up the push to protect the Affordable Care Act?
Wearing a continuous positive airway pressure (CPAP) device not only helps heart failure patients with obstructive sleep apnea get a good night's rest, it lowers blood pressure and heart rate well into the morning, apparently, by reducing sympathetic nervous system activity, according to a new study (PDF) in the June 21, 2005, issue of the Journal of the American College of Cardiology.
› Verified 9 days ago